The hemodialysis vascular grafts market is set to reach from US$ 196.6 Mn in 2017 to US$ 285.2 Mn by 2026 representing balanced growth at a compounded annual growth rate (CAGR) of 4.3% during the forecast period from 2018 to 2026. Atrial fibrillation is the most common type of cardiac arrhythmia diagnosed globally. According to the research findings brought forward by World Health Organization (WHO), the number of end stage renal disease patients worldwide receiving dialysis will be approximately 5.24 million by 2030. The common causes associated with morbidity during hemodialysis are infection, hemorrhage and vascular grafts rejection. Synthetic materials are being made with a blend of polymers to achieve the desired materials strength, adhesion, durability and pliability. Bioengineered materials will be the latest trendsetter due to advantages associated with it such as negligible graft rejection and excellent biocompatibility.

Browse the full report Hemodialysis Vascular Grafts Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/hemodialysis-vascular-grafts-market

Market Insights

End stage renal disease (ESRD) is a medical condition in which the kidney functions only 10% of its natural ability to perform excretion of toxic material from the human blood. When the glomerular filtration rate of the kidney is